Search Results - "intranasal administration"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Between-strain differences in hypothermic response in mice after intranasal administration of PtO nanoparticles by D. V. Petrovskii, A. V. Romashchenko, S. Yu. Troitskii, M. P. Moshkin

    Published 2015-12-01

    Air pollution by particulate matter (PM) has been associated with cardiopulmonary morbidity and mortality in many recent epidemiological studies. It has been shown that transition metal compounds, well- known toxic components of PM, are able to induce hypothermia following whole-body inhalation expo...

    Full description

    Subjects: Get full text
    Article
  2. 2

    Comparative pharmacodynamics of intranasal and enteral administration of captopril for uncomplicated hypertensive crises by I. L. Kechyn, V. V. Hladyshev, I. О. Pukhalska

    Published 2021-03-01

    Uncomplicated hypertensive crises without acute or progressive damage to the target organs pose a potential threat to the patient’s life and require rapid reduction of arterial pressure within hours or days in an outpatient setting. The existing protocol for the treatment of this pathology is not en...

    Full description

    Subjects: Get full text
    Article
  3. 3

    Approaches to the Development of a Low-dose Naltrexone Preparation in the Form of a Nasal Spray (Review) by Yu. M. Domnina, V. V. Suslov, S. A. Kedik, P. O. Volkova

    Published 2021-02-01

    Introduction. Naltrexone hydrochloride belongs to µ-opioid receptor antagonists and is widely used in the treatment of alcohol and drug addiction at an oral dose of 50 mg/day. It is also a blocker of other receptors – opioid growth factor and Toll-like factor, which is especially evident at doses of...

    Full description

    Subjects: Get full text
    Article
  4. 4

    Intranasal Administration as a Route to Deliver Drugs to the Brain (Review) by N. N. Porfiryeva, I. I. Semina, R. I. Moustafine, V. V. Khutoryanskiy

    Published 2021-11-01

    Introduction. Intranasal drug delivery from nose-to-brain is one of the promising approaches for the treatment of brain diseases including neurodegenerative diseases, stroke, brain tumors, etc.Text. Delivery of drugs through the nose has a number of advantages, including the rapid onset of a pharmac...

    Full description

    Subjects: Get full text
    Article
  5. 5

    Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial by Carolina L. Haass-Koffler, Bhavani Kashyap, Brian J. Gully, Sithara S. Nambiar, Rivkah Hornbacher, Stephanie L. Foster, Yuval Silberman, Robert M. Swift, Leah R. Hanson, William H. Frey, II

    Published 2025-08-01

    Despite developments in treatments for alcohol use disorder (AUD), current pharmacotherapies face several limitations, including adverse events. Intranasal (IN) insulin has shown promise for addictive disorders. The overarching hypothesis of this trial is that by increasing brain cell energy and glu...

    Full description

    Subjects: Get full text
    Article
  6. 6

    Pre-Clinical Toxicity Study and Safety Assessment of Candidate Live Pertussis Vaccine for Intranasal Administration by L. N. Sinyashina, E. G. Semin, A. Yu. Medkova, R. A. Siundiukova, G. I. Karataev

    Published 2019-01-01

    Against the backdrop of mass parenteral immunization by present pertussis vaccines the incidence rate of pertussis is recorded in many countries, as well as among adolescents and adults, according to the World Health Organisation data. The number of cases of pertussis complicated to detect is increa...

    Full description

    Subjects: Get full text
    Article
  7. 7

    Olfactory transport efficiency of the manganese oxide nanoparticles (II) after their single or multiple intranasal administrations by A. V. Romashchenko, M. B. Sharapova, D. V. Petrovskii, M. P. Moshkin

    Published 2017-05-01

    In experiments with reusable inhalation of nano-sized metal oxide particles, it has been shown that there is no significant relationship between the number of presentations and the metal concentration in the olfactory bulb. This fact raises the question of a possible decrease in the efficiency of pa...

    Full description

    Subjects: Get full text
    Article
  8. 8

    Study of the possibility of using metformin by intranasal administration for the correction of behavioral and cognitive dysfunctions of rats by A. Z. Hafizova, I. I. Semina

    Published 2025-05-01

    Relevance. Metformin is an antidiabetic agent in the therapy of type 2 diabetes mellitus, which has a complex of pharmacological effects that may allow its use as a geroprotector and a means for the treatment of cognitive and behavioral disorders. Metformin when administered orally has low bioavaila...

    Full description

    Subjects: Get full text
    Article
  9. 9

    Intranasal Dexmedetomidine for Sedation in Acute Ischemic Stroke: A Case Report by Antonio Romanelli, Antonella Langone, Flora Minichino, Renato Gammaldi

    Published 2025-03-01

    This case report presents the innovative use of intranasal dexmedetomidine (IN-DEX) for sedation in an 82-year-old female patient undergoing endovascular treatment (EVT) for acute ischemic stroke (AIS). The patient, with a history of chronic atrial fibrillation, arterial hypertension, and chronic ki...

    Full description

    Subjects: Get full text
    Article
  10. 10

    THE STUDY OF EFFECTS OF THE INTRANASAL DEXMEDETOMIDINE ADMINISTRATION ON PAIN SENSITIVITY by O. I. Rudko, E. A. Klimov, V. V. Sobolev, A. V. Sosnov, K. A. Rufanov, F. M. Semchenko

    Published 2019-01-01

    The development of new antinociceptive agents and new approaches to pain relief based on potent non-narcotic analgesics is one of the most in demand and urgent directions of modern pharmacology. This work substantiates the choice of the clinically most relevant representative of non-narcotic analges...

    Full description

    Subjects: Get full text
    Article
  11. 11

    USING DEXMEDETOMIDINE AS THE MAIN AGENT FOR ANESTHETIC MANAGEMENT DURING RADIOSURGERY IN A CHILD by A. M. Аrefiev, A. Yu. Lubnin, A. S. Kulikov

    Published 2019-01-01

    This clinical case demonstrates specific features of anesthetic management during radiosurgery in pediatric patients considering the limited access to them during continuous manipulations with pharmacological sedation. Considering the age of the child, dexmedetomidine, the drug from the group of ago...

    Full description

    Subjects: Get full text
    Article
  12. 12

    Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration by Wu H, Li C, Yuan H, Zhao J, Li S

    Published 2025-05-01

    Huanhuan Wu,1,2,* Chenyu Li,1,2,* Hong Yuan,3 Jingyuan Zhao,3,* Shuai Li1 1The First Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China; 2Dalian Medical University, Dalian, People’s Republic of China; 3Central Hospital of Dalian U...

    Full description

    Subjects: Get full text
    Article
  13. 13

    Nasal Residence Depending on the Administered Dosage Form: Impact of Formulation Type on the In Vivo Nasal Retention Time of Drugs in Rats by Daisuke Inoue, Yoshihiro Seto, Hideto To

    Published 2025-06-01

    <b>Background/Objectives</b>: The precise control of drug absorption through the nasal mucosa following intranasal administration can be achieved through optimal formulation development that considers the nasal retention properties of the administered dosage form. This study aimed to qua...

    Full description

    Subjects: Get full text
    Article
  14. 14

    Intranasal administration of Ganoderma lucidum-derived exosome-like nanovesicles ameliorates cognitive impairment by reducing inflammation in a mouse model of Alzheimer’s disease by Xue Mi, Xue Mi, Xinglin Ruan, Renyi Lin, Shuxin Huang, Ping Cai, Xiaochun Chen, Xiaochun Chen, Jiangfeng Liao, Xiaoman Dai, Xiaoman Dai

    Published 2025-07-01

    Background/ObjectivesAlthough Alzheimer’s disease (AD) is the most prevalent dementia in late life, with amyloid beta (Aβ) deposition and neuroinflammation are recognized among its primary pathological features. Currently, there is currently still a lack of effective therapeutic drugs for AD. Ganode...

    Full description

    Subjects: Get full text
    Article
  15. 15

    Immunogenicity of GamLPV, an intranasal live vaccine for pertussis prevention, in adult volunteers: a blind, randomised, placebo-controlled trial to optimise the method and schedul... by A. A. Lidzhieva, A. Yu. Medkova, S. V. Kulikov, L. N. Sinyashina, R. A. Sioundioukova, I. N. Chernyshova, M. V. Gavrilova, K. K. Bushkova, N. A. Snegireva, I. N. Dyakov, G. I. Karataev

    Published 2025-04-01

    INTRODUCTION. Currently used inactivated vaccines with acellular/whole-cell pertussis components do not provide sterilising or sufficiently long-lasting immunity, nor do these vaccines prevent the spread of the pathogen or infection. A live pertussis vaccine for intranasal administration, GamLPV, ha...

    Full description

    Subjects: Get full text
    Article
  16. 16

    Intranasal Administration of Cold-Adapted Live-Attenuated Eurasian Avian-like H1N1 Vaccine Candidate Confers Protection Against Different-Lineage H1N1 Viruses in Mice by Qiu Zhong, Zuchen Song, Fei Meng, Yanwen Wang, Yijie Zhang, Zijian Feng, Yali Zhang, Yujia Zhai, Yan Chen, Chuanling Qiao, Hualan Chen, Huanliang Yang

    Published 2025-05-01

    Background/Objectives: Eurasian avian-like (EA) H1N1 swine influenza viruses, with their persistent evolution and zoonotic potential, seriously threaten both swine and human health. The objective was to develop an effective vaccine against these viruses. Methods: A cold-adapted, temperature-sensitiv...

    Full description

    Subjects: Get full text
    Article
  17. 17

    Safety, immunogenicity, and protective efficacy of the intranasal live pertussis vaccine GamLPV in an infant monkey model (<i>Papio hamadryas</i>) by D. T. Kubrava, A. Yu. Medkova, A. Z. Matua, I. G. Kondzariya, A. A. Amichba, Kh. Z. Trapsh, L. V. Gamgiya, S. G. Kulikov, L. N. Sinyashina, Z. Ya. Mikvabiya, G. I. Karataev

    Published 2024-12-01

    INTRODUCTION. The current progressive increase in pertussis incidence and infant mortality rates is due to the insufficient effectiveness of existing vaccines, both in Russia and worldwide. Previous clinical trials showed that healthy adult volunteers developed long-term antibacterial immunity after...

    Full description

    Subjects: Get full text
    Article
  18. 18

    Antiviral Activity of Double-Stranded Ribonucleic Acid and Interferon Alpha Composition in the Model of Experimental Influenza Infection of Mice by S. G. Gamaley, М. O. Skarnovich, E. V. Makarevich, О. Yu. Mazurkov, L. N. Shishkina, О. S. Ivanova, G. M. Levagina, Е. D. Danilenko

    Published 2023-12-01

    High variability of influenza viruses requires the development of agents for nonspecific resistance stimulation, along with the development of new drugs for prevention and treatment. Among the antiviral drugs, interferons and their inducers are known to exhibit a universally wide spectrum of action....

    Full description

    Subjects: “…composition for intranasal administration…”
    Get full text
    Article